In Jun. 2019, Defense Advanced Research Projects Agency (DARPA) announced it had funded a $21.9 gene modulation research initiative at the Georgia Institute of Technology, in collaboration with Centers for Disease Control and Prevention (CDC) and other universities, targeting influenza pandemics.